Platycodin D Attenuates Airway Inflammation in a Mouse Model of Allergic Asthma by Regulation NF-κB Pathway

Inflammation

Volumn 38, Issue 3, 2015, Pages 1221-1228

  Zhang, Tianzhu ^a   Yang, Shihai ^b   Du, Juan ^c   Jinfu, Yao ^a   Shumin, Wang ^a  

^a CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

asthma; NF B pathway; platycodin D

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; I KAPPA B; I KAPPA B KINASE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NF-KAPPAB INHIBITOR ALPHA; OVALBUMIN; PLANT EXTRACT; PLATYCODIN D; RELA PROTEIN, MOUSE; SAPONIN; TRANSCRIPTION FACTOR RELA; TRITERPENE;

AIRWAY RESISTANCE; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; CAMPANULACEAE; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; EOSINOPHIL; EOSINOPHILIA; FEMALE; IMMUNOLOGY; LUNG; METABOLISM; MOUSE; PATHOLOGY; RANDOMIZATION;

AIRWAY RESISTANCE; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CAMPANULACEAE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EOSINOPHILS; FEMALE; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; PLANT EXTRACTS; RANDOM ALLOCATION; SAPONINS; TRANSCRIPTION FACTOR RELA; TRITERPENES;

EID: 84939937880     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0089-6     Document Type: Article

References (21)

1. Beasley, R., J. Crane, C.K. Lai, and N. Pearce. 2000. Prevalence and etiology of asthma. Journal of Allergy and Clinical Immunology 105: 466–72.
2. Busse, W.W., and R.F. Lemanske Jr. 2001. Asthma. New England Journal of Medicine 344: 350–62.
3. Brightling, C.E., F.A. Symon, S.S. Birring, et al. 2002. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. Journal of Allergy and Clinical Immunology 110: 899–905.
4. Robinson, D.S., Q. Hamid, S. Ying, et al. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. New England Journal of Medicine 326: 298–304.
5. Hershey, G.K. 2003. IL-13 receptors and signaling pathways: an evolving web. Journal of Allergy and Clinical Immunology 111: 677–690.
6. Ci, X., X. Chu, X. Xu, H. Li, and X. Deng. 2012. Short-term roxithromycin treatment attenuates airway inflammation via MAPK/NF-kappaB activation in a mouse model of allergic asthma. Inflammation Research 61: 749–58. 7. L.-K.
7. Han, B., J. Xu, and Y. Kimura. 2000. Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. Journal of Nutrition 130(11): 2760–2764.
8. Han, L.-K., Y.-N. Zheng, B.-J. Xu, H. Okuda, and Y. Kimura. 2002. Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice. Journal of Nutrition 132(8): 2241–2245.
9. Kim, Y.P., E.B. Lee, and S.Y. Kim. 2001. Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Medica 67(4): 362–364.
10. Kim, M.-O., D.-O. Moon, H.C. Yung, J.-D. Lee, D.K. Nam, and G.-Y. Kim. 2008. Platycodin D induces mitotic arrest in vitro, leading to endoreduplication, inhibition of proliferation and apoptosis in leukemia cells. International Journal of Cancer 122(12): 2674–2681.
11. Choi, S.-S., E.-J. Han, T.-H. Lee, et al. 2002. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse. Planta Medica 68(9): 794–798.
12. Xie, Y., H.-X. Sun, and D. Li. 2009. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen. Vaccine 27(5): 757–764.
13. Oh, S.R., M.Y. Lee, K. Ahn, B.Y. Park, O.K. Kwon, H. Joung, J. Lee, D.Y. Kim, S. Lee, J.H. Kim, and H.K. Lee. 2006. Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma. International Immunopharmacology 6: 978–86.
14. Djukanović, R., W.R. Roche, J.W. Wilson, C.R. Beasley, O.P. Twentyman, R.H. Howarth, and S.T. Holgate. 1990. Mucosal inflammation in asthma. American Journal of Respiratory and Cirtical Care Medicine 142: 434–57.
15. Duan, W., J.H. Chan, C.H. Wong, B.P. Leung, and W.S. Wong. 2004. Anti inflammatory effects of mitogen-activated protein kinase inhibitor U0126 in an asthma mouse model. The Journal of Immunology 172: 7053–7059.
16. Wenzel, S.E. 2006. Asthma: defining of the persistent adult phenotypes. Lancet 368: 804–13.
17. Elsner, J., and A. Kapp. 1999. Regulation and modulation of eosinophil effector functions. Allergy 54: 15–22.
18. Haddad, J.J. 2002. Nuclear factor (NF)-kappa B blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1 beta biosynthesis in alveolar epithelial cells. Biochemical and Biophysical Research Communications 293: 252–257.
19. Haeberle, H.A., R. Takizawa, A. Casola, A.R. Brasier, H.J. Dieterich, N. Van Rooijen, et al. 2002. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. Journal of Infectious Diseases 186: 1199–1206.
20. Poynter, M.E., C.G. Irvin, and Y.M. Janssen-Heininger. 2002. Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. American Journal of Pathology 160: 1325–1334.
21. Yang, L., L. Cohn, D.H. Zhang, R. Homer, A. Ray, and P. Ray. 1998. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. Journal of Experimental Medicine 188: 1739–1750.